256 related articles for article (PubMed ID: 21343254)
21. Phosphate depletion in the rat: effect of bisphosphonates and the calcemic response to PTH.
Jara A; Lee E; Stauber D; Moatamed F; Felsenfeld AJ; Kleeman CR
Kidney Int; 1999 Apr; 55(4):1434-43. PubMed ID: 10201008
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
[TBL] [Abstract][Full Text] [Related]
23. PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet.
Dayer R; Brennan TC; Rizzoli R; Ammann P
Osteoporos Int; 2010 Jun; 21(6):957-67. PubMed ID: 19859647
[TBL] [Abstract][Full Text] [Related]
24. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
[TBL] [Abstract][Full Text] [Related]
25. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
26. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients.
Fiedler R; Deuber HJ; Langer T; Osten B; Mohan S; Jehle PM
Nephron Clin Pract; 2004; 96(1):c3-9. PubMed ID: 14752247
[TBL] [Abstract][Full Text] [Related]
27. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
[TBL] [Abstract][Full Text] [Related]
28. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
29. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
30. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
Ueno Y; Shinki T; Nagai Y; Murayama H; Fujii K; Suda T
J Cell Biochem; 2003 Oct; 90(2):267-77. PubMed ID: 14505343
[TBL] [Abstract][Full Text] [Related]
31. Effects of vitamin K2 administration on calcium balance and bone mass in young rats fed normal or low calcium diet.
Iwamoto J; Yeh JK; Takeda T; Sato Y
Horm Res; 2005; 63(5):211-9. PubMed ID: 15886487
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
Linkhart TA; Keffer MJ
Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
[TBL] [Abstract][Full Text] [Related]
33. Impact of energy and casein or whey protein intake on bone status in a rat model of age-related bone loss.
Mardon J; Zangarelli A; Walrand S; Davicco MJ; Lebecque P; Demigné C; Horcajada MN; Boirie Y; Coxam V
Br J Nutr; 2008 Apr; 99(4):764-72. PubMed ID: 17925049
[TBL] [Abstract][Full Text] [Related]
34. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
Ahmad AM; Thomas J; Clewes A; Hopkins MT; Guzder R; Ibrahim H; Durham BH; Vora JP; Fraser WD
J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
[TBL] [Abstract][Full Text] [Related]
35. Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients.
Sorva A; Välimäki M; Risteli J; Risteli L; Elfving S; Takkunen H; Tilvis R
Eur J Clin Invest; 1994 Dec; 24(12):806-12. PubMed ID: 7705374
[TBL] [Abstract][Full Text] [Related]
36. Effects of dietary sodium chloride loading on parathyroid function, 1,25-dihydroxyvitamin D, calcium balance, and bone metabolism in female rats during chronic prednisolone administration.
Goulding A; Gold E
Endocrinology; 1986 Nov; 119(5):2148-54. PubMed ID: 3769866
[TBL] [Abstract][Full Text] [Related]
37. Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I.
Halloran BP; Spencer EM
Endocrinology; 1988 Sep; 123(3):1225-9. PubMed ID: 3402383
[TBL] [Abstract][Full Text] [Related]
38. TSH prevents bone resorption and with calcitriol synergistically stimulates bone formation in rats with low levels of calciotropic hormones.
Dumic-Cule I; Draca N; Luetic AT; Jezek D; Rogic D; Grgurevic L; Vukicevic S
Horm Metab Res; 2014 May; 46(5):305-12. PubMed ID: 24446158
[TBL] [Abstract][Full Text] [Related]
39. Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone.
Samadfam R; Xia Q; Miao D; Hendy GN; Goltzman D
J Bone Miner Res; 2008 Aug; 23(8):1257-66. PubMed ID: 18348699
[TBL] [Abstract][Full Text] [Related]
40. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
